Universal Health Services提升了2026年利润预期并提高了股息，而UnitedHealth和United Therapeutics则公布了强劲的盈利。 Universal Health Services raised 2026 profit outlook and raised dividend, while UnitedHealth and United Therapeutics reported strong earnings.

普遍保健服务机构报告,2025年Q4收入为每股5.88美元,略低于估计数,但将其2026年全年EPS指南提高到22.64-24.52美元,超过了共识。 Universal Health Services reported Q4 2025 earnings of $5.88 per share, slightly below estimates, but raised its 2026 full-year EPS guidance to $22.64–$24.52, exceeding consensus. 该公司还宣布季度股息为每股0.20美元。 The company also announced a quarterly dividend of $0.20 per share. 超过平均数的股票份额增加0.80美元至230.78美元。 Shares rose $0.80 to $230.78 on above-average volume. UHS在美国和国际各地经营医院、外科中心和行为卫生设施。 UHS operates hospitals, surgical centers, and behavioral health facilities across the U.S. and internationally. 与此同时,联合健康集团报告了强的2026年第三季度业绩,每股收益为2.11美元,收入为1137亿美元,均高于预期,并重申了2026年每股收益指标为17.75美元. Meanwhile, UnitedHealth Group reported strong Q3 2026 results, with EPS of $2.11 and revenue of $113.73 billion, both above expectations, and reaffirmed its 2026 EPS guidance at $17.75. 联合治疗公司在公布第四季度每股7.70美元盈利后，股价上涨9%，超出预期，尽管收入预测未达预期。 United Therapeutics saw its stock jump 9% after reporting Q4 earnings of $7.70 per share, surpassing estimates, despite missing revenue forecasts.